The system begins with the treatment of raw or drinking water through possible pretreatment steps such as softening, activated carbon filtration, particle filtration, and, if necessary, UV disinfection. Subsequently, desalination units are used to reduce conductivity and non-condensable gases. Single- or double-stage reverse osmosis, degassing systems, electrode ionization (EDI), and ultrafiltration (UF) are employed to generate the required residual conductivity—in order to achieve the necessary purity according to pharmaceutical standards.
 The piping design takes into account all necessary aspects to prevent microbial growth in the system. Furthermore, emptying and CIP (clean-in-place) of individual desalination components are possible. The surface finish meets specifications with a roughness of < 0.8 µm and can be further refined. Numerous sampling points ensure reliably controlled PW (polycyclic aromatic hydrocarbon) production.
 Automation monitors all critical parameters such as conductivity, TOC, temperature, and pressure, ensuring system integrity within the GMP framework.
 Special features / characteristics:

 
 Hygienic CIP/SIP-compatible design in accordance with GMP requirements
 
 PW performance can be specified in the acceptance pattern within a range of from/to.
 
 AISI 316L electropolished, welds according to DIN/ASME BPE
 
 FDA, EMA, cGMP and GAMP compliant design
 
 Automation via Siemens or Rockwell PLC with remote maintenance access
 
 Integrated sensors (conductivity, TOC, online microbiological measurement)
 
 Modular skid design for easy installation and expansion


 👉 Advantage:
 Consistently high purity of ultrapure water quality according to pharmaceutical standards with minimal operating costs and full GMP compliance.